Correlation Between Alpha Tau and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Alpha Tau and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alpha Tau and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alpha Tau Medical and Champions Oncology, you can compare the effects of market volatilities on Alpha Tau and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alpha Tau with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alpha Tau and Champions Oncology.

Diversification Opportunities for Alpha Tau and Champions Oncology

0.83

Correlation Coefficient

Alpha Tau  Champions Oncology

Very poor diversification

The 3 months correlation between Alpha and Champions is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Alpha Tau Medical and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Alpha Tau is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alpha Tau Medical are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Alpha Tau i.e., Alpha Tau and Champions Oncology go up and down completely randomly.

Pair Corralation between Alpha Tau and Champions Oncology

Given the investment horizon of 90 days Alpha Tau is expected to generate 1.49 times less return on investment than Champions Oncology. But when comparing it to its historical volatility, Alpha Tau Medical is 1.6 times less risky than Champions Oncology. It trades about 0.26 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  437.00  in Champions Oncology on October 22, 2024 and sell it today you would earn a total of  541.00  from holding Champions Oncology or generate 123.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Alpha Tau Medical  vs.  Champions Oncology

Alpha Tau Medical

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Tau Medical are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Alpha Tau unveiled solid returns over the last few months and may actually be approaching a breakup point.

Champions Oncology

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alpha Tau and Champions Oncology

The main advantage of trading using opposite Alpha Tau and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alpha Tau position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Alpha Tau Medical and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.